Kiniksa Pharmaceuticals International (KNSA) Return on Assets (2021 - 2025)
Historic Return on Assets for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to 0.05%.
- Kiniksa Pharmaceuticals International's Return on Assets rose 2000.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.08% for FY2024, which is 400.0% up from last year.
- As of Q3 2025, Kiniksa Pharmaceuticals International's Return on Assets stood at 0.05%, which was up 2000.0% from 0.01% recorded in Q2 2025.
- In the past 5 years, Kiniksa Pharmaceuticals International's Return on Assets ranged from a high of 0.68% in Q2 2023 and a low of 0.68% during Q4 2021
- In the last 5 years, Kiniksa Pharmaceuticals International's Return on Assets had a median value of 0.05% in 2025 and averaged 0.0%.
- Per our database at Business Quant, Kiniksa Pharmaceuticals International's Return on Assets skyrocketed by 12600bps in 2022 and then tumbled by -8400bps in 2024.
- Over the past 5 years, Kiniksa Pharmaceuticals International's Return on Assets (Quarter) stood at 0.68% in 2021, then soared by 185bps to 0.58% in 2022, then tumbled by -121bps to 0.12% in 2023, then soared by 36bps to 0.08% in 2024, then soared by 169bps to 0.05% in 2025.
- Its Return on Assets stands at 0.05% for Q3 2025, versus 0.01% for Q2 2025 and 0.03% for Q1 2025.